Pathophysiological Aspects of Proteases in Cancer

Capture the cutting edge of cancer research with Pathophysiological Aspects of Proteases in Cancer by Sajal Chakraborti, Srijit Das, and Cheorl‑Ho Kim — an essential resource for clinicians, cancer researchers, and graduate students worldwide. This authoritative volume unpacks the complex roles of proteases in tumor initiation, progression, metastasis, and the tumor microenvironment, bridging molecular mechanisms with clinical implications.

Beginning with clear, evidence-based overviews of protease families and regulatory networks, the book progresses to translational topics: biomarkers for diagnosis and prognosis, protease-driven signaling pathways, and the latest advances in protease-targeted therapies. Case studies and regionally relevant clinical perspectives make the content practical for oncology centers in North America, Europe, and Asia-Pacific, while maintaining global applicability for laboratory scientists and pharmaceutical developers.

Readers will gain actionable insights into how proteases influence angiogenesis, immune evasion, and metastatic niches, and how these discoveries inform the development of inhibitors, diagnostics, and combination treatments. Written by leading experts, the text balances rigorous science with clear explanations—ideal for anyone seeking to deepen their understanding of cancer pathophysiology and identify new research or therapeutic opportunities.

Whether you’re advancing a research program, designing clinical trials, or updating a medical library, this book offers the depth and clarity necessary to stay at the forefront of protease biology in oncology. Order your copy today to integrate molecular insight with clinical strategy and accelerate progress against cancer across the globe.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.